Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study
The Journal of Clinical Hypertension Jan 24, 2018
Oliveras A, et al. - Researchers intended to examine the effect of renal denervation and spironolactone on preclinical target organ damage in patients with resistant hypertension. A reduction in albuminuria was noted in patients with resistant hypertension treated with spironolactone as compared with renal denervation at 6 months.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
